Crohn’s Disease

Crohn’s disease is an inflammatory bowel disease caused by an abnormality in the functioning of the immune system and the accumulation of white blood cells in the intestinal tract. As a result auto-antibodies attack the lining of the gut resulting in chronic inflammation, swelling, bleeding. Patients complain of loss of appetite, malnutrition and weight loss, diarrhea, abdominal cramps, mucus and blood in the stool leading to anemia. The disease evolves overtime with symptom-free periods of remission alternating with episodes of recurrence of acute symptoms and relapses. This changing of pattern varies in degree from patient to patient. Estimates of 500,000 Americans are diagnosed with Crohn’s disease.

The goals of the treatment are to decrease the inflammatory process, control the symptoms and correct the nutritional deficiencies. Until now, with the use of specific restricted diets, combined with strong drugs that aim at suppressing the body immune function, physicians were only able to control the disease and limit the number and the intensity of the relapses; this was certainly not seen as potential cure.

Recent studies shows that stem cell therapy may play an important role in the future for the treatment of Crohn’s disease by offering a way to reset the immune system to a more normal function, thus decreasing the inflammatory process in the bowel and repairing and replacing damaged intestinal linings.  Preliminary results show that both allogenic stem cells (from umbilical cord) and autologous stem cells extracted from the patient’s own peripheral blood or bone marrow could be effective treatment for refractory Crohns’ disease.

Cellulogix offers cell therapy for Crohn’s disease that includes both umbilical cord blood stem cell treatment and/ or stem cell aphaeresis with the use of your own stem cells collected from your peripheral blood.

In addition, our cell therapy is combined with a holistic comprehensive approach of the disease process. The entire treatment takes five days to complete. Our program includes lifestyle and diet recommendations as well as personalized natural supplements prescription for gastrointestinal tract repair and immune system support.

Patients are followed up at regular intervals, post stem cell therapy to monitor their progress.

Industry News

Stanford University Awarded over $5M for Research

Stanford University Medical Center. Four researchers at the Stanford University School of Medicine have been awarded just over $5.5 million for their stem cell research projects.
The California Institute for Regenerative Medicine is now funding projects that are attempting to find ways to overcome immune system rejection of transplanted stem cells. The institute is the state [...]

Read More

Patient Shares Comments Re: His Progress Since Treatment for Ataxia

Dear Cellulogix:   I’m Phil D. and I had my transplant the week of May 5th 2009.  We have communicated several times in the past but not lately. I had my 13th month post transplant exam with my Neurologist yesterday June 18th and thought Dr.Nabavi and you would be interested in an update on my condition. [...]

Read More

New Stem Cell Center At UC Irvine

Hub of hope and healing
Dedication of UCI’s Gross Hall is milestone in effort to unlock stem cells’ potential
 Daniel A. Anderson / University Communications
The May 14 dedication of UCI’s Sue & Bill Gross Hall: A CIRM Institute was a milestone in the effort to unlock stem cells’ potential. Here, CIRM fellows are briefed before leading guest [...]

Read More

Need to Send Medical Records?

Cellulogix recently added the Doc’s@cellulogix email address for our patients to send in their medical reports and all other pertinent information that may be requested. This is helpful if you want our team of specialists to have your medical information prior to your initial consultation as well as follow up reports that are requested.

Read More